News

DXA screening: You’re doing it wrong


 

FROM THE JOURNAL OF GENERAL INTERNAL MEDICINE

References

Dual-energy x-ray absorptiometry to screen for osteoporosis is both underused in women who meet the U.S. Preventive Services Task Force criteria for screening, and overused in low-risk younger women, new data suggest.

A retrospective, longitudinal cohort study of 50,995 women attending 13 primary care clinics found that among previously unscreened women who met the criteria for screening, the 7-year cumulative incidence of DXA screening ranged from 58.8% in women aged 60-64 years with at least one risk factor, to 42.7% in women aged 75 years and older.

©iStock / ThinkStockPhotos.com

But among women who didn’t meet screening criteria, the 7-year cumulative incidence was 45.5% in women aged 50-59 years and 58.6% in women aged 60-64 years without risk factors, according to a paper published May 19 in the Journal of General Internal Medicine (doi:10.1007/s11606-015-3349-8).

The U.S. Preventive Services Task Force currently recommends screening for osteoporosis with DXA for women aged 65 and older, as well as young women at increased risk for fracture. The American Academy of Family Physicians also advised against DXA screening in women younger than age 65 without osteoporosis risk factors as part of the “Choosing Wisely” campaign.

“Additional research is needed to elucidate patient, physician, and health system barriers to evidence-based screening so that interventions can maximize the value of population screening for osteoporosis,” wrote Dr. Anna Lee D. Amarnath of the University of California, Davis Health System, and her coauthors.

The study was supported by the National Institutes of Health and the Agency for Healthcare Research and Quality. The researchers reported having no financial disclosures.

Recommended Reading

Vitamin D landscape marked by lack of consensus
MDedge Endocrinology
Osteoporosis medication use down in older women
MDedge Endocrinology
Varying cutoffs of vitamin D add confusion to field
MDedge Endocrinology
Hot flashes linked to increased hip fracture risk
MDedge Endocrinology
Look for adverse events in patients with chronic urticaria
MDedge Endocrinology
Oral bisphosphonates linked with lower risk of endometrial cancer
MDedge Endocrinology
Universal bisphosphonates after wrist fracture prevent hip fractures but at a cost
MDedge Endocrinology
Hip replacements not just for the elderly anymore
MDedge Endocrinology
NASPAG: Hormonal add-back prevents GnRH-A–related bone loss in adolescents
MDedge Endocrinology
OARSI: Bisphosphonate users less likely to undergo knee replacement
MDedge Endocrinology